摘要
慢性阻塞性肺疾病(COPD)作为全球第三大死因,对公共卫生构成重大威胁,其早期症状不明显,常导致诊断和治疗的延误,因此早期识别COPD对改善患者预后至关重要.本文对现有的COPD筛查工具进行了汇总,包括慢性阻塞性肺疾病诊断问卷(CDQ)、改良CDQ、慢性阻塞性肺疾病人群筛查问卷(COPD-PS)、慢性阻塞性肺疾病评估测试(CAT)量表、肺功能问卷(LFQ)、改良LFQ、慢性阻塞性肺疾病筛查问卷(COPD-SQ)、COPD风险七项评分量表、在初级保健医院中进行慢性阻塞性肺疾病评估以鉴定未诊断的肺部疾病及恶化风险问卷(CAPTURE)、萨尔茨堡慢性阻塞性肺疾病筛查问卷(SCSQ)、COPD-MH问卷,并分析了其在早期识别COPD中的应用价值、优势和局限性,提出未来研究和实践应聚焦于进一步优化各COPD筛查工具,以提高其筛查效能和促进COPD的早期诊断和有效管理.
Abstract
Chronic obstructive pulmonary disease(COPD),as the third leading cause of death globally,poses a significant threat to public health.Its early symptoms are not obvious,often leading to delayed diagnosis and treatment.Therefore,early identification is crucial for improving the patients'prognosis.This article summarizes existing COPD screening tools,including COPD Diagnostic Questionnaires(CDQ),modified CDQ,COPD Population Screener Questionnaire(COPD-PS),COPD Assessment Test(CAT)Scale,Lung Function Questionnaire(LFQ),modified LFQ,COPD Screening Questionnaire(COPD-SQ),COPD Risk Seven Item Rating Scale,COPD Assessment in Primary Care to Identify Undiagnosed Respiratory Disease and Exacerbation Risk Questionnaire(CAPTURE),Salzburg COPD-Screening Questionnaire(SCSQ)and COPD-MH Questionnaire,and analyzes their application value,advantages,and limitations in early identification of COPD.It proposes that future research and practice should focus on further optimizing various COPD screening tools to improve their screening efficiency and promote early diagnosis and effective management of COPD.
维普
万方数据